Immunosuppressive Total Lymphoid Irradiation-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 523-528

  Heinzelmann, Frank ^a   Lang, Peter J ^a   Ottinger, Hellmut ^b   Faul, Christoph ^a   Bethge, Wolfgang ^a   Handgretinger, Rupert ^a   Bamberg, Michael ^a   Belka, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Engraftment; Graft failure; Low toxicity; Reconditioning; Total lymphoid irradiation

Indexed keywords

ANTIBODIES; CELL CULTURE; IRRADIATION; PATIENT TREATMENT; TOXICITY;

ENGRAFTMENT; GRAFT FAILURE; TOTAL LYMPHOID IRRADIATION;

TRANSPLANTATION (SURGICAL);

BUSULFAN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; OKT 3; T LYMPHOCYTE ANTIBODY; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHILD; DISEASE FREE SURVIVAL; ENGRAFTMENT; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LYMPH NODE IRRADIATION; ORGAN DONOR; PEDIATRICS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; GRAFT REJECTION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHATIC IRRADIATION; MIDDLE AGED; MUROMONAB-CD3; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMONIA; RETREATMENT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 38149054153     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.037     Document Type: Article

References (27)

1. Heinzelmann F., Ottinger H., Muller C.H., et al. Total-body irradiation-Role and indications: Results from the German Registry for Stem Cell Transplantation (DRST). Strahlenther Onkol 182 (2006) 222-230
2. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338 (1998) 962-968
3. Kernan N.A., Bartsch G., Ash R.C., et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328 (1993) 593-602
4. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 29 (2002) 545-552
5. Grandage V.L., Cornish J.M., Pamphilon D.H., et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 21 (1998) 687-690
6. Stucki A., Leisenring W., Sandmaier B.M., et al. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood 92 (1998) 2742-2749
7. Wright S.E., Thomas E.D., Buckner C.D., et al. Experience with second marrow transplants. Exp Hematol 4 (1976) 221-226
8. Storb R., Weiden P.L., Sullivan K.M., et al. Second marrow transplants in patients with aplastic anemia rejecting the first graft: Use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 70 (1987) 116-121
9. Schlegel P.G., Eyrich M., Bader P., et al. OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. Br J Haematol 111 (2000) 668-673
10. Gaziev D., Giardini C., Galimberti M., et al. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: Long-term follow-up from a single center. Bone Marrow Transplant 24 (1999) 253-257
11. Gaziev D., Polchi P., Lucarelli G., et al. Second marrow transplants for graft failure in patients with thalassemia. Bone Marrow Transplant 24 (1999) 1299-1306
12. Slavin S., Or R., Naparstek E., et al. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation. Isr J Med Sci 22 (1986) 264-267
13. Kaplan H.S. Selective effects of total lymphoid irradiation (TLI) on the immune response. Transplant Proc 13 (1981) 425-428
14. Lowsky R., Takahashi T., Liu Y.P., et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 353 (2005) 1321-1331
15. Movsas B., Raffin T.A., Epstein A.H., et al. Pulmonary radiation injury. Chest 111 (1997) 1061-1076
16. Heinzelmann F., Jendrossek V., Lauber K., et al. Irradiation-induced pneumonitis mediated by the CD95/CD95-ligand system. J Natl Cancer Inst 98 (2006) 1248-1251
17. Mehta J., Powles R., Singhal S., et al. Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant 17 (1996) 213-217
18. Davies S.M., Weisdorf D.J., Haake R.J., et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 14 (1994) 73-77
19. Cobos E., Keung Y.K., Morgan D., et al. Successful engraftment using allogeneic peripheral blood progenitor cells in a patient with primary bone marrow graft failure. J Hematother 4 (1995) 37-40
20. Keil F., Kalhs P., Haas O.A., et al. Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: Successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion. Br J Haematol 94 (1996) 120-122
21. Bader P., Klingebiel T., Klingel K., et al. Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia. Bone Marrow Transplant 16 (1995) 479-481
22. Slavin S., Naparstek E., Aker M., et al. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant Proc 21 (1989) 3053-3054
23. Zapatero A., Marin A., Lopez M., et al. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up. Hematol Oncol 14 (1996) 165-172
24. Coleman C.N., Williams C.J., Flint A., et al. Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 297 (1977) 1249-1252
25. Al-Qurashi F., Ayas M., Al Sharif F., et al. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Hematology 9 (2004) 123-129
26. Guardiola P., Kuentz M., Garban F., et al., French Society of Bone Marrow Transplantation. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. Br J Haematol 111 (2000) 292-302
27. Shah A.J., Kapoor N., Weinberg K.I., et al. Second hematopoietic stem cell transplantation in pediatric patients: Overall survival and long-term follow-up. Biol Blood Marrow Transplant 8 (2002) 221-228